1 Correction to: European Journal of Drug Metabolism and Pharmacokinetics (2021) 46:277–287 https://doi.org/10.1007/s13318-020-00669-7

The original version of this article unfortunately contained a few errors. The correct information is given below:


Page 281, 1st paragraph, 2nd sentence, which previously read:


The serum samples in TR02-112 were clustered in two primary windows—0–4 h and 12–24 h postdose (Fig. 1).


Should read:


The serum samples in TR02-112 were clustered in two primary windows—0–4 h and 12–24 h postdose (Fig. 2).


Figure 2: The 24- and 48-hour labels on the x-axis in Figure 2 were transposed. The corrected version of Fig. 2 is given below:

Figure 2
figure 2

Observed serum amikacin concentration versus time sinces last dose. Closed and open circles represent individual values for patients in CONVERT and TR02-112 studies, respectively. Amikacin concentrations that were BLQ are shown at LLOQ (i.e., 0.15 mg/L). One BLQ concentration in the TR02-112 study, observed at > 500 h after the previous dose, was excluded; it was retained in the population pharmacokinetic dataset but did not impact the model fit. BLQ below the limit of quantification; LLOQ lower limit of quantification

Full size image

The corrected version of supplementary file is updated here.